Quarterly report pursuant to Section 13 or 15(d)

Organization and Business - Narrative (Details)

v3.22.2.2
Organization and Business - Narrative (Details)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Jan. 22, 2021
USD ($)
shares
Jan. 19, 2021
USD ($)
shares
Mar. 31, 2021
USD ($)
Sep. 30, 2022
USD ($)
Sep. 30, 2022
USD ($)
patent
Dec. 31, 2021
USD ($)
May 28, 2021
USD ($)
Debt Instrument [Line Items]              
Number of patents issued | patent         17    
Number of pending patents | patent         8    
Cash, cash equivalents, and marketable securities       $ 7,700,000 $ 7,700,000    
Net working capital       5,900,000 5,900,000    
Accumulated deficit       153,080,771 153,080,771 $ 143,951,019  
Sale of stock, consideration received on transaction $ 6,250,000 $ 8,000,000          
Shares authorized amount (in shares) | shares 5,681,817 13,333,334          
Payments to acquire investments     $ 2,000,000        
Cash deposited, interest-bearing     $ 10,000,000        
Sales Agreement              
Debt Instrument [Line Items]              
Sale of stock, consideration received on transaction, authorized amount             $ 35,000,000
Number of days for advance notice             10 days
Commission fee, percent             3.00%
Money Market Funds and Marketable Debt and Equity Securities              
Debt Instrument [Line Items]              
Deposits       $ 4,200,000 $ 4,200,000    
Net Revenue | Customer Concentration Risk | Customer One              
Debt Instrument [Line Items]              
Percentage of concentration risk       33.10% 26.10%    
Net Revenue | Customer Concentration Risk | Customer Two              
Debt Instrument [Line Items]              
Percentage of concentration risk       30.00% 26.40%    
Net Revenue | Customer Concentration Risk | Customer Three              
Debt Instrument [Line Items]              
Percentage of concentration risk       10.90% 9.10%    
Net Revenue | Customer Concentration Risk | Customer One, Two, and Three              
Debt Instrument [Line Items]              
Percentage of concentration risk       74.00% 61.60%    
Accounts Receivable | Customer Concentration Risk | Customer One, Two, and Three              
Debt Instrument [Line Items]              
Percentage of concentration risk         70.30% 34.30%